Thymus, thymoma and myasthenia gravis
- PMID: 22948665
- DOI: 10.1007/s00595-012-0318-2
Thymus, thymoma and myasthenia gravis
Abstract
Myasthenia gravis is an autoimmune disease. An autoantibody directed toward acetylcholine receptor (AChR) causes the destruction of the postsynaptic membrane and a reduction of the number of AChRs at neuromuscular junctions. A very puzzling, but interesting characteristic of myasthenia gravis is that many of the patients have an abnormality in their thymus. Many have a hyperplastic thymus with germinal centers, while others have a thymic tumor. How is the abnormality of the thymus related to myasthenia gravis? This review will summarize the existing evidence and try to find the missing link between the thymus and myasthenia gravis. The review will also comment on two distinct populations of myasthenia gravis patients without thymoma. The autoimmunity found in elderly patients is nonspecific and initiated via a different mechanism from the initiation of myasthenia gravis in younger patients.
Similar articles
-
Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.Int Immunol. 2003 Aug;15(8):903-13. doi: 10.1093/intimm/dxg088. Int Immunol. 2003. PMID: 12882828
-
Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.Ann N Y Acad Sci. 1998 May 13;841:538-41. doi: 10.1111/j.1749-6632.1998.tb10978.x. Ann N Y Acad Sci. 1998. PMID: 9668290 No abstract available.
-
Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.Ann Neurol. 1992 Oct;32(4):589-91. doi: 10.1002/ana.410320419. Ann Neurol. 1992. PMID: 1333745
-
Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance.Ann N Y Acad Sci. 1998 May 13;841:505-15. doi: 10.1111/j.1749-6632.1998.tb10971.x. Ann N Y Acad Sci. 1998. PMID: 9668283 Review. No abstract available.
-
The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.Ann N Y Acad Sci. 1976;274:493-515. doi: 10.1111/j.1749-6632.1976.tb47710.x. Ann N Y Acad Sci. 1976. PMID: 786115 Review.
Cited by
-
Risk Factors and Outcomes in Cats with Acquired Myasthenia Gravis (2001-2012).J Vet Intern Med. 2015 Sep-Oct;29(5):1307-12. doi: 10.1111/jvim.13596. Epub 2015 Aug 26. J Vet Intern Med. 2015. PMID: 26308738 Free PMC article.
-
Pure Red Cell Aplasia and Other Haematological Diseases Associated With Thymoma: A Case Series and Systematic Review.Front Med (Lausanne). 2021 Dec 13;8:759914. doi: 10.3389/fmed.2021.759914. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34966753 Free PMC article.
-
Myasthenia gravis as a prognostic marker in patients with thymoma.J Thorac Dis. 2018 May;10(5):2842-2848. doi: 10.21037/jtd.2018.04.95. J Thorac Dis. 2018. PMID: 29997948 Free PMC article.
-
Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients.Int J Environ Res Public Health. 2023 Feb 9;20(4):3039. doi: 10.3390/ijerph20043039. Int J Environ Res Public Health. 2023. PMID: 36833734 Free PMC article.
-
Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy.Oncol Lett. 2016 Jun;11(6):4177-4182. doi: 10.3892/ol.2016.4528. Epub 2016 May 5. Oncol Lett. 2016. PMID: 27313762 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical